Low-dose versus standard-dose intravenous alteplase for octogenerian acute ischemic stroke patients: A multicenter prospective cohort study

Author:

Chao A-Ching,Han Ke,Lin Sheng-FengORCID,Lin Ruey-Tay,Chen Chih-Hung,Chan LungORCID,Lin Huey-Juan,Sun Yu,Lin Yung-Yang,Chen Po-Lin,Lin Shinn-Kuang,Wei Cheng-Yu,Lin Yu-Te,Lee Jiunn-Tay,Hu Han-Hwa,Bai Chyi-HueyORCID

Funder

Ministry of Science and Technology, taiwan

KMUH

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference14 articles.

1. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT);Yamaguchi;Stroke,2006

2. Different doses of recombinant tissue-type plasminogen activator for acute stroke in Chinese patients;Chao;Stroke,2014

3. B.J. Kim, M.K. Han, T.H. Park, S.S. Park, K.B. Lee, B.C. Lee, K.H. Yu, M.S. Oh, J.K. Cha, D.H. Kim, J. Lee, S.J. Lee, Y. Ko, J.M. Park, K. Kang, Y.J. Cho, K.S. Hong, J.T. Kim, J.C. Choi, D.E. Kim, D.I. Shin, W.J. Kim, J.S. Lee, B.W. Yoon, P.B. Gorelick, H.J. Bae, Low-versus standard-dose alteplase for ischemic strokes within 4.5 hours: a comparative effectiveness and safety study, Stroke 46(9) (2015) 2541–8.

4. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses;Liao;Stroke,2014

5. Outcomes of thrombolytic therapy for acute ischemic stroke in Chinese patients: the Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) study;Chao;Stroke,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3